X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5504) 5504
Publication (207) 207
Book Review (75) 75
Magazine Article (24) 24
Book Chapter (8) 8
Newsletter (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4528) 4528
male (3061) 3061
imipramine - therapeutic use (3028) 3028
female (2674) 2674
adult (2162) 2162
imipramine (2146) 2146
psychiatry (1839) 1839
middle aged (1676) 1676
depressive disorder - drug therapy (1237) 1237
antidepressive agents - therapeutic use (1072) 1072
pharmacology & pharmacy (1067) 1067
aged (888) 888
animals (876) 876
double-blind method (875) 875
depression - drug therapy (873) 873
adolescent (784) 784
psychiatric status rating scales (735) 735
treatment outcome (730) 730
antidepressive agents, tricyclic - therapeutic use (701) 701
depression (685) 685
clinical trials as topic (680) 680
antidepressants (657) 657
index medicus (652) 652
neurosciences (632) 632
depressive disorder - psychology (621) 621
child (590) 590
clinical neurology (557) 557
imipramine - adverse effects (550) 550
imipramine - pharmacology (519) 519
rats (508) 508
double-blind (471) 471
placebos (456) 456
placebo (423) 423
major depression (416) 416
dose-response relationship, drug (408) 408
fluoxetine (407) 407
amitriptyline - therapeutic use (381) 381
time factors (356) 356
serotonin uptake inhibitors - therapeutic use (355) 355
imipramine - administration & dosage (338) 338
drug therapy, combination (312) 312
depression, mental (302) 302
mice (295) 295
efficacy (287) 287
psychology, clinical (282) 282
amitriptyline (268) 268
antidepressive agents - pharmacology (267) 267
psychotherapy (265) 265
bipolar disorder - drug therapy (263) 263
antidepressive agents - adverse effects (258) 258
follow-up studies (258) 258
anxiety (253) 253
j ve psychiatry (252) 252
combined modality therapy (249) 249
fluoxetine - therapeutic use (249) 249
child, preschool (247) 247
drug administration schedule (246) 246
enuresis - drug therapy (245) 245
drug therapy (234) 234
serotonin (229) 229
tricyclic antidepressants (225) 225
anxiety disorders - drug therapy (222) 222
depressive disorder, major - drug therapy (219) 219
desipramine - therapeutic use (219) 219
imipramine - blood (218) 218
antidepressive agents, tricyclic - adverse effects (216) 216
panic disorder - drug therapy (215) 215
recurrence (214) 214
disease models, animal (211) 211
antidepressant (208) 208
antidepressive agents, second-generation - therapeutic use (206) 206
desipramine (203) 203
panic disorder (203) 203
comorbidity (195) 195
paroxetine (189) 189
care and treatment (188) 188
depressive disorder - diagnosis (188) 188
monoamine oxidase inhibitors - therapeutic use (184) 184
severity of illness index (176) 176
agoraphobia (175) 175
drugs (172) 172
sertraline (172) 172
medicine, general & internal (170) 170
research (167) 167
age factors (165) 165
lithium - therapeutic use (165) 165
brain (164) 164
outpatients (164) 164
analysis (162) 162
alprazolam (161) 161
antidepressive agents, tricyclic - pharmacology (161) 161
randomized controlled trials as topic (160) 160
ambulatory care (159) 159
rats, wistar (158) 158
chronic disease (155) 155
drug interactions (155) 155
depressive disorder - therapy (151) 151
personality inventory (149) 149
analysis of variance (146) 146
pharmacotherapy (146) 146
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4999) 4999
German (153) 153
French (109) 109
Italian (48) 48
Russian (47) 47
Polish (44) 44
Japanese (43) 43
Spanish (26) 26
Czech (18) 18
Norwegian (16) 16
Danish (15) 15
Portuguese (14) 14
Swedish (10) 10
Dutch (9) 9
Romanian (6) 6
Chinese (2) 2
Croatian (2) 2
Hungarian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Drugs, ISSN 0012-6667, 4/2011, Volume 71, Issue 6, pp. 771 - 790
Concerns about paraphilia and its treatment have grown in the past few years. Although the aetiology of paraphilia disorder is still not completely understood,... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Medroxyprogesterone, therapeutic use | Escitalopram, therapeutic use | Paraphilias, diagnosis | Paroxetine,therapeutic use | Sertraline, therapeutic use | Cyproterone, therapeutic use | Fluoxetine, therapeutic use | Leuprorelin, therapeutic use | Clomipramine, therapeutic use | Nefazodone, therapeutic use | Gonadotropin-releasing-hormone-stimulants, therapeutic use | Imipramine, therapeutic use | Fluvoxamine, therapeutic use | Triptorelin, therapeutic use | Serotonin-uptake-inhibitors, therapeutic use | Paraphilias, epidemiology | Paraphilias, treatment | SEROTONIN REUPTAKE INHIBITORS | COMPULSIVE SEXUAL-BEHAVIOR | FLUOXETINE TREATMENT | MALE-RAT | GONADOTROPIN-RELEASING-HORMONE | MEDROXYPROGESTERONE ACETATE | PSYCHIATRIC COMORBIDITY | CYPROTERONE-ACETATE | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TOXICOLOGY | LEUPROLIDE ACETATE | Humans | Gonadotropin-Releasing Hormone - administration & dosage | Gonadotropin-Releasing Hormone - adverse effects | Male | Treatment Outcome | Combined Modality Therapy | Gonadotropin-Releasing Hormone - analogs & derivatives | Paraphilic Disorders - drug therapy | Antidepressive Agents - therapeutic use | Psychotherapy - methods | Androgen Antagonists - therapeutic use | Antidepressive Agents - administration & dosage | Paraphilic Disorders - psychology | Gonadotropin-Releasing Hormone - therapeutic use | Androgen Antagonists - administration & dosage | Antidepressive Agents - adverse effects | Androgen Antagonists - adverse effects | Paraphilic Disorders - epidemiology | Sexual deviation | Care and treatment | Hormone therapy | Research | Diagnosis | Social aspects | Health aspects
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Psychosomatic Medicine, ISSN 0033-3174, 2016, Volume 78, Issue 1, pp. 102 - 112
Objective Depression and Type 2 diabetes mellitus are interrelated conditions, but the underlying neurobiology is insufficiently understood. The current study... 
Antidepressant | AMPK | Insulin resistance | AICAR | Exercise | Nitric oxide | nitric oxide | MUSCLE GLUCOSE-UPTAKE | PSYCHIATRY | antidepressant | INCREASES | exercise | MAJOR DEPRESSION | PROTEIN-KINASE ACTIVITY | PSYCHOLOGY | SKELETAL-MUSCLE | BRAIN MITOCHONDRIA | PSYCHOLOGY, MULTIDISCIPLINARY | insulin resistance | HIPPOCAMPAL NEUROGENESIS | EXPRESSION | DEPRESSION-LIKE BEHAVIORS | Diet, High-Fat - adverse effects | Depressive Disorder - drug therapy | Male | Aminoimidazole Carboxamide - pharmacology | Ribonucleotides - pharmacology | Corticosterone - toxicity | Adenylate Kinase - metabolism | Triazenes - pharmacology | Depressive Disorder - therapy | Antidepressive Agents - pharmacology | Depressive Disorder - chemically induced | Ketamine - therapeutic use | Fluoxetine - therapeutic use | Triazenes - therapeutic use | Drug Evaluation, Preclinical | Physical Conditioning, Animal | Disease Models, Animal | Fluoxetine - pharmacology | Imipramine - therapeutic use | Aminoimidazole Carboxamide - therapeutic use | Mice, Inbred C57BL | Insulin Resistance | Nitric Oxide - physiology | Combined Modality Therapy | Enzyme Activation - drug effects | NG-Nitroarginine Methyl Ester - therapeutic use | Antidepressive Agents - therapeutic use | Nerve Tissue Proteins - metabolism | Ribonucleotides - therapeutic use | Animals | Aminoimidazole Carboxamide - analogs & derivatives | Prefrontal Cortex - metabolism | Mice | Imipramine - pharmacology | Ketamine - pharmacology
Journal Article